Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit
GALVESTON, Texas--(BUSINESS WIRE)--Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego. “Based on preclinical…